Literature DB >> 21327674

Idiopathic retroperitoneal fibrosis with particular perirenal and intrarenal extension associated with left renal artery stenosis. The atheromatous periaortitis with retroperitoneal fibrosis suggests a pathogenic relationship between atherosclerosis and fibrosis?

Gheorghe Gluhovschi1, Gheorghe Bozdog, Gratian Miclaus, Tudor Puscasiu, Cristina Gluhovschi, Flaviu Bob, Silvia Velciov, Ligia Petrica, Virginia Trandafirescu, Florica Gadalean.   

Abstract

We present a case of idiopathic retroperitoneal fibrosis (RPF) in a female patient of 45 years, obese (BMI = 39 kg/sqm), hypertensive since 2005, with diabetes mellitus treated with diet and diabetes insipidus in whom, during a routine control, the following has been found: serum creatinine 1.74 mg/dl, and an inflammatory syndrome associated with fever. Spiral-CT (Multi-slice-Sensation 64) scan shows retroperitoneal fibrosis in relation with periaortitis that affects the thoracic and abdominal aorta. RPF is extending perirenally and at the level of the renal hilum with subsequent calyceal dilations (hydrocalycosis) associated with left renal artery stenosis. The particularity of the case is represented by the perirenal and intrarenal evolution of fibrosis with left renal artery stenosis with moderate impairment of renal function reversible under treatment with Tamoxifen. This case, with chronic periaortitis subsequent to an extended aortic atherosclerosis with retroperitoneal fibrosis can be representative for the pathogenic relationship between atherosclerosis and fibrosis.

Entities:  

Mesh:

Year:  2011        PMID: 21327674     DOI: 10.1007/s00508-011-1539-x

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  13 in total

1.  Case 83: multifocal fibrosclerosis with mediastinal-retroperitoneal involvement.

Authors:  Gilberto Szarf; David A Bluemke
Journal:  Radiology       Date:  2005-06       Impact factor: 11.105

Review 2.  [Is there an evidence-based management of idiopathic retroperitoneal fibrosis?].

Authors:  E Maillart; L Lauerière; S Kassis; L Moulonguet-Doleris; J Prinseau; A Baglin; T Hanslik
Journal:  Rev Med Interne       Date:  2006-06-21       Impact factor: 0.728

Review 3.  [Idiopathic retroperitoneal fibrosis treated with tamoxifen. A case report and review of the bibliography].

Authors:  J Barquero-Romero; L Márquez Velázquez
Journal:  Rev Clin Esp       Date:  2007-04       Impact factor: 1.556

4.  Retroperitoneal fibrosis with azotaemia secondary to metastatic breast cancer.

Authors:  V Srinivas; D Dow
Journal:  Br J Urol       Date:  1986-04

5.  Inflammatory aneurysms of the abdominal aorta.

Authors:  D I Walker; K Bloor; G Williams; I Gillie
Journal:  Br J Surg       Date:  1972-08       Impact factor: 6.939

6.  Treatment of retroperitoneal fibrosis with tamoxifen.

Authors:  R M Spillane; G J Whitman
Journal:  AJR Am J Roentgenol       Date:  1995-02       Impact factor: 3.959

7.  Age-related changes in the abdominal aorta shown by computed tomography.

Authors:  A K Dixon; J P Lawrence; J R Mitchell
Journal:  Clin Radiol       Date:  1984-01       Impact factor: 2.350

8.  The response of retroperitoneal fibrosis to tamoxifen.

Authors:  C P Clark; D Vanderpool; J T Preskitt
Journal:  Surgery       Date:  1991-04       Impact factor: 3.982

Review 9.  Retroperitoneal fibrosis.

Authors:  Augusto Vaglio; Carlo Salvarani; Carlo Buzio
Journal:  Lancet       Date:  2006-01-21       Impact factor: 79.321

10.  Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis.

Authors:  D V Parums; D L Brown; M J Mitchinson
Journal:  Arch Pathol Lab Med       Date:  1990-04       Impact factor: 5.534

View more
  1 in total

1.  The Role of Multidetector CT in the Diagnosis of Retroperitoneal Fibrosis: Report of a Case.

Authors:  Hossein Ghanaati; Mehdi Mohammadifar; Mahsa Ghajarzadeh; Kavous Firouznia; Marzieh Motevalli; Amir Hossein Jalali
Journal:  Iran J Radiol       Date:  2012-03-25       Impact factor: 0.212

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.